COVID-19 IMI2–Call 21
CARE launched to accelerate therapy development against COVID-19 and future coronavirus threats.
Search
EMPRISE
Learn about the EMPRISE real-world evidence study and use of empagliflozin in routine clinical care. Click here to find out more information.
Poultry farming drives sustainability
The Village Poultry Project & Making More Health strive to make poultry farming sustainable. Click here to find out more information about this.
COVID-19 Spain - Volunteering for good causes in Spain
Three Boehringer Ingelheim employees in Spain have stepped forward to help out during the COVID-19 pandemic. Click here to find out and learn more.
Expectations towards our business partners
Boehringer Ingelheim utilises an extensive network of international suppliers. Click here to learn more about our expectations towards our suppliers.
Boehringer Ingelheim allocates COVID relief fund to support underserved communities and patients in India
Boehringer Ingelheim is making available a Euro One Million COVID relief fund to support underserved communities and patients in India. Learn more here.
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management. Click here to find out more information.
EHS management approach
Our comprehensive EHS framework describes our EHS management system at a corporate level consisting of four elements. Click here to find out more.
COVID-19 Volunteering in Wuhan China
Boehringer Ingelheim is striving to support community residents and the Wuhan community during this epidemic. Click here to find out and learn more.
Afrika Kommt! - The Ripple Effect
What the Afrika Kommt! Fellowship Program means to Boehringer Ingelheim
COVID-19: Research Update
Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19. Learn more.
BI Access to Healthcare Strategy_Availability
Through our Access to Healthcare Strategy, we want to ensure that our compounds are readily and responsibly available. Learn more about our work here.
COVID-19 Relief Efforts in China
Since the outbreak of the Coronavirus disease in China in late January, Boehringer Ingelheim has quickly decided to make a number of donations. Read more.
COVID-19 USA U.S. employees show gratitude #foreachother
Employees across the U.S. display Boehringer Ingelheim’s culture of caring during this challenging time. Click here to find out and learn more.
Pet industry trends Millennials
Millennials are now shaping pet markets and facing new issues in pet healthcare. Click here to read and learn more about this new generation of pet owners.
Cat care interview veterinarian Dr Susan Little
We interviewed world-renowned feline healthcare specialist Dr Susan Little to get her thoughts on cat care. Click here to read and find out more.
COVID-19 Germany - Sports videos for staying fit at home
Aline Nichtern, Head of the Boehringer Ingelheim Sports Centre, offers an online sports programme for all home office employees. Click here to learn more.
COVID-19 Emotional support for physicians in Mexico
As part of the efforts to help different sectors, Boehringer Ingelheim México created the Emotional Containment Program for Health Care Professionals.
COVID-19 COVID-19 Southeast Asia Donations
Beyond direct support of the healthcare community on the ground, several organisations are receiving support in Southeast Asia & South Korea. Learn more.
Performance Indicators
All available performance indicators concerning Environment Health and Safety (EHS) are summarised here. Click here to find out more information.
Co-creation with Communities
Making More Health has launched co-creation projects in Asia, Africa, Europe and other localities around the world with top social entrepreneurs.
Solidarity with Ukraine
Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term. Click here to learn more.
The METAmorphosis
At Boehringer Ingelheim’s META offices in the Middle East, Turkey and Africa all offices in the region are already free of single-use plastic. Learn more.
COVID-19 Boehringer Ingelheim Clinical Trials
We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.
Boehringer Ingelheim China for a green future
Together with all other functions, Fangya Qiang oversees the MORE GREEN programme at Boehringer Ingelheim’s Chinese locations. Click here to learn more.